Early Stage

Build a Heart. Save a life.

Build a Heart. Save a life.


Raised to Date: Raised: $275,333

Total Commitments ($USD)


Dalmore Group

Start Date


Close Date

Not Provided

Min. Goal
Max. Goal
Min. Investment


Security Type

Equity - Common

SEC Filing Type

RegA+    Open SEC Filing

Price Per Share


Rolling Commitments ($USD)

Reporting Date


% of Min. Goal
% of Max. Goal
Likelihood of Max
Avg. Daily Raise


# of Investors


Create a free account today to gain access to KingsCrowd analytics.
Year Founded



Healthcare & Pharmaceuticals

Tech Sector



Buffalo Grove, Illinois

BioLife4D is raising funds on Dalmore Group through Reg A+ crowdfunding. The company aims to use the current advances in cardiac tissue engineering to build human hearts suitable for implantation. The company will use 3D bioprinting to make patient-specific hearts using the patients’ own cells. The hearts of BioLife4D will have a precise fit and a perfect genetic match. BioLife4D has printed a mini-heart and working on a functional mini-heart for toxicity testing. Steven Morris founded BioLife4D in 2016. The current crowdfunding campaign has no minimum target and a maximum target of $46,133,806. The campaign proceeds will be used for marketing, salaries, rent, equipment, licenses, and working capital.

Balance Sheet

Cash and Cash Equivalents


Total Assets


Accounts Payable & Accrued Liabilities


Long Term Debt


Total Liabilities


Total Stockholders' Equity


Total Liabilities and Equity


Statement of Comprehensive Income Information

Costs & Expenses Applicable to Rev


Net Income


Earnings Per Share - Basic


Earnings Per Share - Diluted


Auditor: IndigoSpire
Financials as of: 10/23/2020
Create a free account today to gain access to KingsCrowd analytics.

Upgrade to gain access

Pay Monthly
Annually (Save 17%)


$25 /month
billed annually
Free portfolio tracking, data-driven ratings, AI analysis and reports
Plan Includes:
Everything in Free, plus
Company specific KingsCrowd ratings and analyst reports
Deal explorer and side-by-side comparison
Startup exit and failure tracking
Startup market filters and historical industry data
Advanced company search ( with ratings)
Get Edge Annual
Already a member? Log in here.
Founders: enhance your startup's credibility on KingsCrowd. Create an account to claim this raise page.

Create your first portfolio

Create your own startup investment portfolio on KingsCrowd.

Track all of your startup investments in one place using our state-of-the-art portfolio tracker tools. To begin, create your first portfolio below.

Add to portfolio
BioLife4D on Dalmore Group 2020
Platform: Dalmore Group
Security Type: Equity - Common
Price per Share: $13.50

Follow company

Follow BioLife4D on Dalmore Group 2020

Buy BioLife4D's Deal Report

Warning: according to the close date for this deal, BioLife4D may no longer be accepting investments.

BioLife4D Deal Report

Get KingsCrowd’s comprehensive report on BioLife4D including:

  • How our proprietary algorithm rates their current capital raise (1-5 stars)
  • Detailed price, market, team, differentiators, performance, and risk ratings
  • Whether BioLife4D is undervalued or overvalued
  • Scores on the founding team and key personnel's background and expertise

Buy the BioLife4D deal report for only $10!

Email address:
Looking to buy more than one deal report? Get unlimited reports by upgrading to Edge